D.R. Horton, Nvidia, and Vertex Pharma forecast significant stock growth due to market advantages.

The article forecasts significant stock growth for D.R. Horton, Nvidia, and Vertex Pharmaceuticals. D.R. Horton is positioned to benefit from a housing shortage and potential interest rate cuts. Nvidia's upcoming Blackwell GPUs promise reduced costs and energy use, driving revenue growth. Vertex Pharmaceuticals anticipates boosts from its CRISPR therapy Casgevy and expected approvals for new treatments, enhancing its market potential.

September 14, 2024
3 Articles